ASH:NYE-Ashland Global Holdings Inc. (USD)

EQUITY | Specialty Chemicals | New York Stock Exchange

Last Closing

USD 88.87

Change

-0.22 (-0.25)%

Market Cap

USD 7.05B

Volume

0.35M

Analyst Target

USD 88.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ashland Global Holdings Inc, formerly Ashland Inc is a speciality chemicals company. It provides products, services and solutions that meet customer needs throughout a variety of industries.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
APD Air Products and Chemicals Inc

+4.11 (+1.47%)

USD 63.17B
LYB LyondellBasell Industries NV

-0.68 (-0.72%)

USD 30.81B
PPG PPG Industries Inc

+1.49 (+1.19%)

USD 29.43B
DLY DoubleLine Yield Opportunities..

-0.05 (-0.30%)

USD 27.84B
ALB Albemarle Corp

-1.06 (-1.20%)

USD 10.28B
AXTA Axalta Coating Systems Ltd

+0.28 (+0.81%)

USD 7.57B
ESI Element Solutions Inc

+0.32 (+1.26%)

USD 6.05B
FUL H B Fuller Company

+1.39 (+1.75%)

USD 4.40B
AVNT Avient Corp

+1.15 (+2.50%)

USD 4.20B
ALTM Arcadium Lithium plc

-0.02 (-0.81%)

USD 4.08B

ETFs Containing ASH

CB1TX:SW Lyxor 1 TecDAX (DR) UCITS.. 12.55 % 0.00 %

+0.16 (+0.50%)

N/A
E908:XETRA Lyxor 1 TecDAX (DR) UCITS.. 12.00 % 0.00 %

+0.22 (+0.50%)

USD 0.09B
EXS2:XETRA iShares TecDAX® UCITS ET.. 11.46 % 0.00 %

+0.27 (+0.50%)

USD 0.77B
EXIB:XETRA iShares TecDAX® UCITS ET.. 11.46 % 0.00 %

+0.04 (+0.50%)

USD 0.77B
TDXPEX:SW iShares TecDAX® UCITS ET.. 11.46 % 0.00 %

N/A

USD 5,933.97B
EGRE:XETRA BNP Paribas Easy ESG Grow.. 7.07 % 0.00 %

+0.10 (+0.50%)

USD 0.07B
EGRO:PA BNP Paribas Easy ESG Grow.. 7.07 % 0.00 %

+0.11 (+0.50%)

N/A
PCIG Litman Gregory Funds Trus.. 6.17 % 0.00 %

+0.05 (+0.50%)

N/A
EGRA:SW WisdomTree Eurozone Quali.. 4.37 % 0.00 %

N/A

N/A
EGRG:LSE WisdomTree Eurozone Quali.. 4.29 % 0.00 %

+9.75 (+0.50%)

USD 0.05B
WTIM:F WisdomTree Eurozone Quali.. 4.14 % 0.00 %

+0.03 (+0.50%)

USD 0.07B
EMOM:SW 3.59 % 0.00 %

N/A

N/A
DIVS SmartETFs Dividend Builde.. 3.07 % 0.00 %

+0.16 (+0.50%)

USD 0.03B
IPXE:LSE First Trust IPOX® Europe.. 2.71 % 0.00 %

+0.44 (+0.50%)

N/A
E908:F Lyxor 1 - TecDAX UCITS ET.. 0.00 % 0.00 %

N/A

N/A
EXS2:F iShares TecDAX UCITS ETF .. 0.00 % 0.00 %

+0.12 (+0.50%)

N/A
F751:F 0.00 % 0.00 %

N/A

N/A
F751:XETRA 0.00 % 0.00 %

N/A

N/A
WTIM:XETRA WisdomTree Eurozone Quali.. 0.00 % 0.00 %

+0.17 (+0.50%)

USD 0.07B
GRNV:AU VanEck MSCI Australian Su.. 0.00 % 0.00 %

+0.22 (+0.50%)

USD 0.17B
MVW:AU VanEck Vectors Australian.. 0.00 % 0.00 %

+0.15 (+0.50%)

USD 2.42B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.41% 60% D- 48% F
Dividend Return 0.94% 41% F 25% F
Total Return 6.35% 53% F 42% F
Trailing 12 Months  
Capital Gain 1.45% 46% F 28% F
Dividend Return 1.78% 51% F 27% F
Total Return 3.23% 41% F 25% F
Trailing 5 Years  
Capital Gain 21.34% 44% F 56% F
Dividend Return 8.38% 33% F 27% F
Total Return 29.72% 44% F 50% F
Average Annual (5 Year Horizon)  
Capital Gain 7.92% 43% F 64% D
Dividend Return 9.38% 43% F 62% D
Total Return 1.46% 46% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 21.44% 80% B- 49% F
Risk Adjusted Return 43.75% 67% D+ 63% D
Market Capitalization 7.05B 64% D 76% C+

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.99 33% 29%
Price/Book Ratio 1.46 56% 55%
Price / Cash Flow Ratio 17.90 25% 21%
Price/Free Cash Flow Ratio 20.88 15% 16%
Management Effectiveness  
Return on Equity 5.63% 33% 45%
Return on Invested Capital 4.04% 28% 42%
Return on Assets 1.21% 22% 39%
Debt to Equity Ratio 42.43% 71% 64%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector